ADRB2 inhibition combined with antioxidant treatment alleviates lung fibrosis by attenuating TGFβ/SMAD signaling in lung fibroblasts

Idiopathic pulmonary fibrosis is a progressive and fatal interstitial lung disease with a poor prognosis and limited therapeutic options, which is characterized by aberrant myofibroblast activation and pathological remodeling of the extracellular matrix, while the mechanism remains elusive. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Ruyan, Wang, Lan, Duan, Yudi, Zhu, Miaomiao, Li, Wenwen, Zhao, Mengxia, Yuan, Hongmei, Xu, Kai, Li, Zhongzheng, Zhang, Xiao, Yu, Guoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624856/
https://www.ncbi.nlm.nih.gov/pubmed/37923730
http://dx.doi.org/10.1038/s41420-023-01702-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624856/
https://www.ncbi.nlm.nih.gov/pubmed/37923730
http://dx.doi.org/10.1038/s41420-023-01702-9

Ejemplares similares